Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
216 | 3904 | 38.5 | 79% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
230 | 3 | P GLYCOPROTEIN//FMO3//TRIMETHYLAMINURIA | 49374 |
747 | 2 | P GLYCOPROTEIN//MULTIDRUG RESISTANCE//MDR1 | 12474 |
216 | 1 | MULTIDRUG RESISTANCE//P GLYCOPROTEIN//PSC 833 | 3904 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | MULTIDRUG RESISTANCE | authKW | 1052330 | 23% | 15% | 887 |
2 | P GLYCOPROTEIN | authKW | 917457 | 21% | 15% | 802 |
3 | PSC 833 | authKW | 154422 | 1% | 49% | 40 |
4 | MDR | authKW | 131303 | 3% | 14% | 117 |
5 | S9788 | authKW | 112989 | 0% | 85% | 17 |
6 | MDR1 | authKW | 101719 | 3% | 13% | 104 |
7 | SDZ PSC 833 | authKW | 91047 | 0% | 61% | 19 |
8 | MDR1 GENE | authKW | 86420 | 1% | 27% | 41 |
9 | MRK16 | authKW | 80428 | 0% | 86% | 12 |
10 | MDR GENES | authKW | 74129 | 0% | 59% | 16 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 43319 | 54% | 0% | 2116 |
2 | Hematology | 6431 | 13% | 0% | 507 |
3 | Pharmacology & Pharmacy | 1905 | 15% | 0% | 590 |
4 | Cell Biology | 734 | 9% | 0% | 351 |
5 | Biochemistry & Molecular Biology | 401 | 13% | 0% | 509 |
6 | Biophysics | 217 | 4% | 0% | 150 |
7 | Pathology | 152 | 2% | 0% | 97 |
8 | Medicine, Research & Experimental | 83 | 3% | 0% | 116 |
9 | Urology & Nephrology | 61 | 2% | 0% | 76 |
10 | Medical Laboratory Technology | 57 | 1% | 0% | 35 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | UROLUROONCOL | 17593 | 0% | 75% | 3 |
2 | LDDRD | 15639 | 0% | 100% | 2 |
3 | MED BRANCH INTERNAL MED NEPHROL | 15639 | 0% | 100% | 2 |
4 | MED WINSHIP CANC MICROCHEM IL | 15639 | 0% | 100% | 2 |
5 | EA 1529 | 10425 | 0% | 67% | 2 |
6 | FORMAT RECH ASSOCIEE CLAUDE BERNARD TRAITEMENT HE | 10425 | 0% | 67% | 2 |
7 | IMUNOL TUMORAL CIENCIAS SAUDE | 10425 | 0% | 67% | 2 |
8 | BIOCHEM CLIN PHARMACOL 332 N LAUDERDALE | 10050 | 0% | 43% | 3 |
9 | MDR GRP | 10050 | 0% | 43% | 3 |
10 | ABT ALLEGEMEINE PADIATRIE HAMATOL ONKOL 1 | 7820 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ANTICANCER RESEARCH | 13947 | 5% | 1% | 186 |
2 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 12509 | 3% | 1% | 109 |
3 | CANCER RESEARCH | 10793 | 6% | 1% | 235 |
4 | BRITISH JOURNAL OF CANCER | 10704 | 4% | 1% | 158 |
5 | JAPANESE JOURNAL OF CANCER RESEARCH | 10101 | 2% | 2% | 68 |
6 | SELECTIVE CANCER THERAPEUTICS | 8190 | 0% | 13% | 8 |
7 | LEUKEMIA | 7011 | 2% | 1% | 83 |
8 | BIOCHEMICAL PHARMACOLOGY | 6020 | 3% | 1% | 121 |
9 | INTERNATIONAL JOURNAL OF CANCER | 5881 | 3% | 1% | 125 |
10 | ANTI-CANCER DRUGS | 5441 | 1% | 1% | 48 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MULTIDRUG RESISTANCE | 1052330 | 23% | 15% | 887 | Search MULTIDRUG+RESISTANCE | Search MULTIDRUG+RESISTANCE |
2 | P GLYCOPROTEIN | 917457 | 21% | 15% | 802 | Search P+GLYCOPROTEIN | Search P+GLYCOPROTEIN |
3 | PSC 833 | 154422 | 1% | 49% | 40 | Search PSC+833 | Search PSC+833 |
4 | MDR | 131303 | 3% | 14% | 117 | Search MDR | Search MDR |
5 | S9788 | 112989 | 0% | 85% | 17 | Search S9788 | Search S9788 |
6 | MDR1 | 101719 | 3% | 13% | 104 | Search MDR1 | Search MDR1 |
7 | SDZ PSC 833 | 91047 | 0% | 61% | 19 | Search SDZ+PSC+833 | Search SDZ+PSC+833 |
8 | MDR1 GENE | 86420 | 1% | 27% | 41 | Search MDR1+GENE | Search MDR1+GENE |
9 | MRK16 | 80428 | 0% | 86% | 12 | Search MRK16 | Search MRK16 |
10 | MDR GENES | 74129 | 0% | 59% | 16 | Search MDR+GENES | Search MDR+GENES |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | GOTTESMAN, MM , PASTAN, I , (1993) BIOCHEMISTRY OF MULTIDRUG-RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER.ANNUAL REVIEW OF BIOCHEMISTRY. VOL. 62. ISSUE . P. 385-427 | 162 | 72% | 3198 |
2 | ENDICOTT, JA , LING, V , (1989) THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCE.ANNUAL REVIEW OF BIOCHEMISTRY. VOL. 58. ISSUE . P. 137-171 | 143 | 82% | 2015 |
3 | FORD, JM , HAIT, WN , (1990) PHARMACOLOGY OF DRUGS THAT ALTER MULTIDRUG RESISTANCE IN CANCER.PHARMACOLOGICAL REVIEWS. VOL. 42. ISSUE 3. P. 155-199 | 187 | 63% | 1010 |
4 | BOSCH, I , CROOP, J , (1996) P-GLYCOPROTEIN MULTIDRUG RESISTANCE AND CANCER.BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER. VOL. 1288. ISSUE 2. P. F37-F54 | 234 | 72% | 85 |
5 | BELLAMY, WT , DALTON, WS , (1994) MULTIDRUG-RESISTANCE IN THE LABORATORY AND CLINIC.ADVANCES IN CLINICAL CHEMISTRY, VOL 31. VOL. 31. ISSUE . P. 1-61 | 229 | 80% | 60 |
6 | VAN DE VRIE, W , MARQUET, RL , STOTER, G , DE BRUIJN, EA , EGGERMONT, AMM , (1998) IN VIVO MODEL SYSTEMS IN P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCE.CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES. VOL. 35. ISSUE 1. P. 1-57 | 166 | 75% | 33 |
7 | AVENDANO, C , MENENDEZ, JC , (2002) INHIBITORS OF MULTIDRUG RESISTANCE TO ANTITUMOR AGENTS (MDR).CURRENT MEDICINAL CHEMISTRY. VOL. 9. ISSUE 2. P. 159 -193 | 196 | 49% | 125 |
8 | SONNEVELD, P , LIST, AF , (2001) CHEMOTHERAPY RESISTANCE IN ACUTE MYELOID LEUKAEMIA.BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY. VOL. 14. ISSUE 1. P. 211 -233 | 133 | 85% | 24 |
9 | FORD, JM , HAIT, WN , (1993) PHARMACOLOGICAL CIRCUMVENTION OF MULTIDRUG-RESISTANCE.CYTOTECHNOLOGY. VOL. 12. ISSUE 1-3. P. 171-212 | 190 | 70% | 106 |
10 | BRADLEY, G , JURANKA, PF , LING, V , (1988) MECHANISM OF MULTIDRUG RESISTANCE.BIOCHIMICA ET BIOPHYSICA ACTA. VOL. 948. ISSUE 1. P. 87-128 | 109 | 89% | 769 |
Classes with closest relation at Level 1 |